ICU MEDICAL INC/DE (ICUI)
Every FINRA and SEC series the site collects for ICU MEDICAL INC/DE: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
1.4M
Short interest
settlement 2026-08-31
6.7
Days to cover
+3.5% vs prior
58.3%
Short share of volume
2026-09-17
76
Fails to deliver
settlement 2026-08-31
Thu 18 Feb
Next earnings
estimated; last year 2026-02-19
-$6.6M
Insider flow, 90 days
0 buys, 13 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in ICUI is 1,433,092 shares, up 45,386 shares over the last month. Over the last 48 readings it ranged from 582,421 shares (15 November 2024) to 1,837,896 shares (29 May 2026). At the reported average volume of 213K shares a day that is 6.7 days to cover, elevated.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/icui" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 1,433,092 | +3.5% | 212,627 | 6.74 |
| 2026-08-14 | 1,384,259 | -0.3% | 387,620 | 3.57 |
| 2026-07-31 | 1,387,706 | -24.3% | 284,963 | 4.87 |
| 2026-07-15 | 1,832,002 | +8.7% | 273,381 | 6.70 |
| 2026-06-30 | 1,685,563 | -4.9% | 369,104 | 4.57 |
| 2026-06-15 | 1,773,120 | -3.5% | 260,030 | 6.82 |
| 2026-05-29 | 1,837,896 | +12.6% | 334,937 | 5.49 |
| 2026-05-15 | 1,632,597 | +0.3% | 292,571 | 5.58 |
| 2026-04-30 | 1,628,295 | +25.2% | 273,067 | 5.96 |
| 2026-04-15 | 1,300,677 | -0.3% | 244,643 | 5.32 |
| 2026-03-31 | 1,304,985 | +9.5% | 305,771 | 4.27 |
| 2026-03-13 | 1,191,690 | +6.1% | 285,715 | 4.17 |
| 2026-02-27 | 1,123,583 | +10.3% | 319,273 | 3.52 |
| 2026-02-13 | 1,018,208 | -10.7% | 261,112 | 3.90 |
| 2026-01-30 | 1,140,705 | -0.7% | 255,079 | 4.47 |
| 2026-01-15 | 1,148,474 | -5.3% | 221,241 | 5.19 |
| 2025-12-31 | 1,212,276 | -7.9% | 207,604 | 5.84 |
| 2025-12-15 | 1,315,759 | -0.6% | 213,254 | 6.17 |
| 2025-11-28 | 1,324,011 | +0.3% | 254,760 | 5.20 |
| 2025-11-14 | 1,319,642 | -12.7% | 376,364 | 3.51 |
| 2025-10-31 | 1,512,385 | +18.0% | 228,137 | 6.63 |
| 2025-10-15 | 1,281,919 | -6.3% | 212,616 | 6.03 |
| 2025-09-30 | 1,368,533 | -5.8% | 308,439 | 4.44 |
| 2025-09-15 | 1,452,107 | +7.5% | 280,486 | 5.18 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of ICUI volume is 58.3%, down 17.4 points over the last five sessions. Over the last 52 readings it ranged from 41.0% (3 August 2026) to 85.6% (9 July 2026). The latest reading is 10.0 points below the 30-session average of 68.3%, on 71K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 41K | 71K | 58.3% | 0 |
| 2026-09-16 | 54K | 78K | 69.4% | 69 |
| 2026-09-15 | 46K | 62K | 74.4% | 0 |
| 2026-09-14 | 55K | 73K | 75.4% | 0 |
| 2026-09-11 | 35K | 75K | 47.0% | 0 |
| 2026-09-10 | 48K | 63K | 75.7% | 0 |
| 2026-09-09 | 97K | 124K | 78.6% | 0 |
| 2026-09-08 | 83K | 104K | 80.5% | 0 |
| 2026-09-04 | 41K | 60K | 69.3% | 0 |
| 2026-09-03 | 63K | 89K | 70.6% | 0 |
| 2026-09-02 | 73K | 101K | 72.3% | 15 |
| 2026-09-01 | 67K | 97K | 68.5% | 5,497 |
| 2026-08-31 | 49K | 79K | 61.6% | 0 |
| 2026-08-28 | 44K | 58K | 75.1% | 4,633 |
| 2026-08-27 | 60K | 103K | 58.5% | 0 |
| 2026-08-26 | 48K | 64K | 74.5% | 0 |
| 2026-08-25 | 35K | 48K | 72.1% | 0 |
| 2026-08-24 | 80K | 104K | 76.8% | 0 |
| 2026-08-21 | 55K | 90K | 60.5% | 2,458 |
| 2026-08-20 | 64K | 123K | 52.5% | 25 |
| 2026-08-19 | 70K | 94K | 73.8% | 0 |
| 2026-08-18 | 73K | 109K | 66.8% | 23 |
| 2026-08-17 | 80K | 100K | 79.4% | 0 |
| 2026-08-14 | 62K | 79K | 77.5% | 0 |
| 2026-08-13 | 55K | 83K | 67.0% | 0 |
| 2026-08-12 | 72K | 102K | 71.2% | 7 |
| 2026-08-11 | 77K | 110K | 70.5% | 0 |
| 2026-08-10 | 110K | 181K | 60.6% | 0 |
| 2026-08-07 | 218K | 437K | 49.8% | 0 |
| 2026-08-06 | 87K | 141K | 61.6% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 31 August 2026, the fails-to-deliver balance in ICUI is 76 shares, down 6,894 shares over the last settlement date. Over the last 52 readings it ranged from 7 shares (16 January 2026) to 26,400 shares (22 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-31 | 76 | $175.10 | $13K |
| 2026-08-18 | 6,970 | $182.51 | $1.3M |
| 2026-07-27 | 719 | $157.44 | $113K |
| 2026-07-16 | 792 | $157.96 | $125K |
| 2026-07-09 | 267 | $151.89 | $41K |
| 2026-07-08 | 40 | $155.37 | $6K |
| 2026-07-06 | 6,699 | $154.97 | $1.0M |
| 2026-06-30 | 827 | $147.93 | $122K |
| 2026-06-22 | 26,400 | $140.37 | $3.7M |
| 2026-06-02 | 369 | $131.64 | $49K |
| 2026-06-01 | 142 | $135.39 | $19K |
| 2026-05-21 | 11 | $129.31 | $1K |
| 2026-05-19 | 185 | $123.08 | $23K |
| 2026-05-18 | 23 | $118.72 | $3K |
| 2026-05-15 | 70 | $122.99 | $9K |
| 2026-05-13 | 28 | $123.23 | $3K |
| 2026-05-12 | 450 | $124.68 | $56K |
| 2026-05-07 | 564 | $119.59 | $67K |
| 2026-04-21 | 72 | $130.58 | $9K |
| 2026-04-20 | 60 | $129.96 | $8K |
| 2026-04-17 | 15 | $126.04 | $2K |
| 2026-04-01 | 48 | $129.15 | $6K |
| 2026-03-31 | 2,671 | $125.38 | $335K |
| 2026-03-26 | 4,881 | $131.38 | $641K |
| 2026-03-25 | 521 | $129.40 | $67K |
| 2026-03-24 | 516 | $129.93 | $67K |
| 2026-03-23 | 4,015 | $125.36 | $503K |
| 2026-03-20 | 2,172 | $126.63 | $275K |
| 2026-03-18 | 780 | $130.55 | $102K |
| 2026-03-16 | 939 | $125.85 | $118K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at ICUI reported 13 open-market sells worth $6.6M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Sanzone Virginia Ruth (VP, General Counsel) on 2026-09-03.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 692 | $171.51 | $119K | 15K |
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 724 | $169.53 | $123K | 15K |
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 1K | $168.44 | $209K | 16K |
| 2026-09-03 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 2K | $167.67 | $369K | 17K |
| 2026-09-01 | Bonnell Brian Michael | Chief Financial Officer | Sell | 6K | $175.00 | $1.1M | 56K |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Sell | 1K | $173.91 | $194K | 62K |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Sell | 5K | $173.44 | $792K | 64K |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Sell | 2K | $172.12 | $329K | 68K |
| 2026-08-31 | Bonnell Brian Michael | Chief Financial Officer | Sell | 2K | $171.05 | $293K | 70K |
| 2026-08-13 | Woolson Daniel | VP, GM-Infusion Capital | Sell | 5K | $181.33 | $982K | 17K |
| 2026-08-12 | Sousa Ben | Chief Information Officer | Sell | 2K | $178.32 | $401K | 3K |
| 2026-08-11 | Voigtlander Christian B. | Chief Operating Officer | Sell | 9K | $182.93 | $1.6M | 37K |
| 2026-08-11 | FINNEY ELISHA W | n/a | Sell | 378 | $182.48 | $69K | 5K |
| 2026-05-22 | Woolson Daniel | President | Sell | 2K | $132.21 | $281K | 22K |
| 2026-05-14 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 2K | $124.08 | $304K | 19K |
| 2026-05-13 | KENNEDY KOLLEEN T | n/a | Option exercise | 1K | $0.00 | $0 | 5K |
| 2026-05-13 | Hoffmeister David F | n/a | Option exercise | 1K | $0.00 | $0 | 6K |
| 2026-05-13 | Hernandez Laurie | n/a | Option exercise | 1K | $0.00 | $0 | 5K |
| 2026-05-13 | Greenberg David C. | n/a | Option exercise | 1K | $0.00 | $0 | 9K |
| 2026-05-13 | FINNEY ELISHA W | n/a | Option exercise | 1K | $0.00 | $0 | 5K |
| 2026-05-13 | Abbey Donald | n/a | Option exercise | 1K | $0.00 | $0 | 6K |
| 2026-05-12 | Greenberg David C. | n/a | Sell | 2K | $122.91 | $298K | 8K |
| 2026-05-12 | Greenberg David C. | n/a | Option exercise | 2K | $101.06 | $245K | 10K |
| 2026-03-25 | Abbey Donald | n/a | J | 704 | $0.00 | $0 | 4K |
| 2026-03-15 | Sousa Ben | Chief Information Officer | Tax withholding | 718 | $125.85 | $90K | 5K |
| 2026-03-15 | Sousa Ben | Chief Information Officer | Option exercise | 1K | $0.00 | $0 | 6K |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Tax withholding | 2K | $125.85 | $226K | 46K |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Option exercise | 3K | $0.00 | $0 | 48K |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Tax withholding | 6K | $125.85 | $793K | 45K |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Option exercise | 11K | $0.00 | $0 | 51K |
| 2026-03-15 | Woolson Daniel | VP, GM-Infusion Capital | Tax withholding | 1K | $125.85 | $163K | 25K |
| 2026-03-15 | Woolson Daniel | VP, GM-Infusion Capital | Option exercise | 3K | $0.00 | $0 | 26K |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Tax withholding | 897 | $125.85 | $113K | 22K |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Option exercise | 2K | $0.00 | $0 | 23K |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Tax withholding | 3K | $125.85 | $396K | 21K |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Option exercise | 6K | $0.00 | $0 | 24K |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Tax withholding | 3K | $125.85 | $339K | 127K |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Option exercise | 5K | $0.00 | $0 | 130K |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Tax withholding | 9K | $125.85 | $1.2M | 125K |
| 2026-03-15 | Jain Vivek | Chairman and CEO | Option exercise | 17K | $0.00 | $0 | 134K |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 2K | $125.85 | $226K | 72K |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Option exercise | 3K | $0.00 | $0 | 74K |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Tax withholding | 6K | $125.85 | $730K | 70K |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Option exercise | 11K | $0.00 | $0 | 76K |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Tax withholding | 529 | $132.00 | $70K | 5K |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Option exercise | 957 | $0.00 | $0 | 5K |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Tax withholding | 4K | $132.00 | $524K | 4K |
| 2026-03-08 | Sousa Ben | Chief Information Officer | Option exercise | 7K | $0.00 | $0 | 8K |
| 2026-03-08 | Voigtlander Christian B. | Chief Operating Officer | Tax withholding | 40K | $132.00 | $5.2M | 40K |
| 2026-03-08 | Voigtlander Christian B. | Chief Operating Officer | Option exercise | 72K | $0.00 | $0 | 79K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON13 Form 144 notices on file for ICUI worth $8.3M at the prices reported; 7 in the last 90 days worth $6.6M. Latest: VIRGINIA SANZONE filed on 2026-09-03 to sell 4,856 shares ($819K) from 2026-09-03.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-03 | VIRGINIA SANZONEOfficer | 5K | $819K | 0.019% | 2026-09-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-01 | BRIAN BONNELLOfficer | 6K | $1.1M | 0.026% | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-31 | BRIAN BONNELLOfficer | 9K | $1.6M | 0.037% | 2026-08-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-13 | DANIEL WOOLSONOfficer | 5K | $982K | 0.022% | 2026-08-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-12 | BENJAMIN SOUSAOfficer | 2K | $401K | 0.009% | 2026-08-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-11 | CHRISTIAN VOIGTLANDEROfficer | 9K | $1.6M | 0.036% | 2026-08-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-11 | ELISHA W FINNEYDirector | 378 | $69K | 0.002% | 2026-08-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-22 | DANIEL WOOLSONOfficer | 2K | $281K | 0.008% | 2026-05-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-14 | VIRGINIA SANZONEOfficer | 2K | $304K | 0.010% | 2026-05-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-12 | DAVID C GREENBERGDirector | 2K | $298K | 0.010% | 2026-05-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-25 | DANIEL WOOLSONOfficer | 3K | $441K | 0.012% | 2025-11-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | VIRGINIA SANZONEOfficer | 930 | $132K | 0.004% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | ELISHA W FINNEYDirector | 1K | $180K | 0.005% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON5 holders above 5% have filed on ICUI, all on Schedule 13G (passive). The largest reported stake is JANUS HENDERSON GROUP Ltd. at 11.1% of the class (2,781,621 shares), filed 2026-08-13 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 3 | Fuller & Thaler Asset Management, Inc.investment adviser | 1.3M | 5.2% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 12 | JANUS HENDERSON GROUP Ltd.parent holding company | 2.8M | 11.1% | 2026-06-30 |
| 2026-05-13 | 13G/Ano. 2 | Fuller & Thaler Asset Management, Inc.investment adviser | 1.2M | 4.9% | 2026-03-31 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 1.3M | 5.2% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 1.5M | 5.8% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding ICUI at their latest 13F. JSON5 of the 30 tracked managers held ICUI at their latest 13F, $117.7M in total at quarter-end prices. Citadel Advisors is the largest at $83.0M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 566K | $83.0M | 0.01% | +224K |
| Point72 Asset Management | 2026-06-30 | 165K | $24.3M | 0.03% | +82K |
| AQR Capital Management | 2026-06-30 | 44K | $6.5M | 0.00% | +29K |
| D. E. Shaw & Co. | 2026-06-30 | 20K | $2.9M | 0.00% | +13K |
| Millennium Management | 2026-06-30 | 7K | $970K | 0.00% | -61K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) ICU MEDICAL INC/DE reported revenue of $551.7M, up 0.5% from the same quarter a year earlier, and net income of $19.1M (0.76 diluted EPS). In FY 2025 it generated $179.8M of operating cash flow and spent $8.8M on buybacks.
- Debt
- $1.23B
- Equity
- $2.15B
- Total assets
- $3.97B
- Shares outstanding
- 25,007,038
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $551.7M | $19.1M | 3.5% | 0.76 |
| Q1 2026 | 2026-03-31 | $530.2M | $30.1M | 5.7% | 1.20 |
| Q4 2025derived | 2025-12-31 | $540.7M | -$15.7M | -2.9% | n/a |
| Q3 2025 | 2025-09-30 | $537.0M | -$3.4M | -0.6% | -0.14 |
| Q2 2025 | 2025-06-30 | $548.9M | $35.3M | 6.4% | 1.43 |
| Q1 2025 | 2025-03-31 | $604.7M | -$15.5M | -2.6% | -0.63 |
| Q4 2024derived | 2024-12-31 | $629.8M | -$23.8M | -3.8% | n/a |
| Q3 2024 | 2024-09-30 | $589.1M | -$33.0M | -5.6% | -1.35 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.23B | $732K | $179.8M | $88.0M | $8.8M | n/a |
| FY 2024 | 2024-12-31 | $2.38B | -$117.7M | $204.0M | $79.4M | $12.0M | n/a |
| FY 2023 | 2023-12-31 | $2.26B | -$29.7M | $166.2M | $83.9M | $9.3M | n/a |
| FY 2022 | 2022-12-31 | $2.28B | -$74.3M | -$62.1M | $90.3M | $10.9M | n/a |
| FY 2021 | 2021-12-31 | $1.32B | $103.1M | $267.5M | $68.5M | $8.3M | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
ICU MEDICAL INC/DE in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows ICU MEDICAL INC/DE (ICUI), SEC CIK 883984, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-31.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-09-03.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-03.JSON and CSV
- Company record
- EDGAR filing index for CIK 883984Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
- BSXBOSTON SCIENTIFIC CORP
- TNDMTANDEM DIABETES CARE INC
- DXCMDEXCOM INC
- PENPenumbra Inc
- SIBNSI-BONE, Inc.
- MMM3M CO
- LMATLEMAITRE VASCULAR INC
- INSPInspire Medical Systems, Inc.
- NVCRNovoCure Ltd
- RMDRESMED INC
- SYKSTRYKER CORP
- GKOSGLAUKOS Corp
- IRTCiRhythm Holdings, Inc.
- ATECAlphatec Holdings, Inc.
- AORTARTIVION, INC.
- PODDINSULET CORP
- BDXBECTON DICKINSON & CO
- IRMDIRADIMED CORP
- ATRCAtriCure, Inc.
- UFPTUFP TECHNOLOGIES INC
- LUNGPulmonx Corp
- MMSIMERIT MEDICAL SYSTEMS INC
- ANGOANGIODYNAMICS INC
- OFIXOrthofix Medical Inc.
Datasets
Frequently Asked Questions
How much of ICUI is sold short?
What is ICUI's daily short volume?
Does ICUI have fails to deliver?
Are ICUI insiders buying or selling?
Have ICUI insiders filed to sell?
Who owns more than 5% of ICUI?
What did ICUI report last quarter?
Which funds hold ICUI?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.